Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
50
CNMD Quote, Financials, Valuation and Earnings
Last price:
$46.02
Seasonality move
:
3.67%
Day range:
$45.22 - $46.55
52-week range:
$35.37 - $64.87
Dividend yield:
1.74%
P/E ratio:
30.36x
P/S ratio:
1.04x
P/B ratio:
1.37x
Volume:
332.1K
Avg. volume:
608.5K
1-year change:
-22.6%
Market cap:
$1.4B
Revenue:
$1.4B
EPS (TTM):
$1.52
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CNMD
CONMED Corp.
|
$366.9M | $1.32 | -2.76% | 322.31% | $47.40 |
|
ELMD
Electromed, Inc.
|
$18M | -- | 11.79% | -- | $37.00 |
|
ESMC
Escalon Medical Corp.
|
-- | -- | -- | -- | -- |
|
GTHP
Guided Therapeutics, Inc.
|
-- | -- | -- | -- | -- |
|
IRIX
IRIDEX Corp.
|
$14.7M | -$0.02 | 10.68% | -50.4% | $3.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CNMD
CONMED Corp.
|
$46.00 | $47.40 | $1.4B | 30.36x | $0.20 | 1.74% | 1.04x |
|
ELMD
Electromed, Inc.
|
$24.07 | $37.00 | $199.2M | 23.43x | $0.00 | 0% | 3.06x |
|
ESMC
Escalon Medical Corp.
|
$0.24 | -- | $1.8M | 154.45x | $0.00 | 0% | 0.21x |
|
GTHP
Guided Therapeutics, Inc.
|
$0.37 | -- | $30.9M | -- | $0.00 | 0% | 150.88x |
|
IRIX
IRIDEX Corp.
|
$1.46 | $3.00 | $25.1M | -- | $0.00 | 0% | 0.48x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CNMD
CONMED Corp.
|
46.21% | 0.814 | 70.58% | 0.94x |
|
ELMD
Electromed, Inc.
|
-- | 0.920 | -- | 4.40x |
|
ESMC
Escalon Medical Corp.
|
31.63% | 2.696 | 43.39% | 1.03x |
|
GTHP
Guided Therapeutics, Inc.
|
-74.91% | 3.813 | 11.94% | 0.01x |
|
IRIX
IRIDEX Corp.
|
50.55% | 0.622 | 18.81% | 1.03x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CNMD
CONMED Corp.
|
$213.3M | $66.9M | 2.49% | 4.72% | 17.91% | $41.2M |
|
ELMD
Electromed, Inc.
|
$14.8M | $3.6M | 20.33% | 20.35% | 19.16% | $2.4M |
|
ESMC
Escalon Medical Corp.
|
$1.6M | $98.7K | -10.13% | -12.94% | 2.75% | -$517.4K |
|
GTHP
Guided Therapeutics, Inc.
|
$8K | -$485K | -- | -- | -808.33% | -$279K |
|
IRIX
IRIDEX Corp.
|
$4M | -$1.4M | -54.1% | -155.93% | -11.3% | -$1.2M |
CONMED Corp. vs. Competitors
-
Which has Higher Returns CNMD or ELMD?
Electromed, Inc. has a net margin of 4.48% compared to CONMED Corp.'s net margin of 14.61%. CONMED Corp.'s return on equity of 4.72% beat Electromed, Inc.'s return on equity of 20.35%.
Company Gross Margin Earnings Per Share Invested Capital CNMDCONMED Corp.57.12% $0.54 $1.9B ELMDElectromed, Inc.78.42% $0.32 $45.4M -
What do Analysts Say About CNMD or ELMD?
CONMED Corp. has a consensus price target of $47.40, signalling upside risk potential of 3.04%. On the other hand Electromed, Inc. has an analysts' consensus of $37.00 which suggests that it could grow by 53.72%. Given that Electromed, Inc. has higher upside potential than CONMED Corp., analysts believe Electromed, Inc. is more attractive than CONMED Corp..
Company Buy Ratings Hold Ratings Sell Ratings CNMDCONMED Corp.0 5 0 ELMDElectromed, Inc.3 0 0 -
Is CNMD or ELMD More Risky?
CONMED Corp. has a beta of 0.967, which suggesting that the stock is 3.283% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.264, suggesting its less volatile than the S&P 500 by 73.581%.
-
Which is a Better Dividend Stock CNMD or ELMD?
CONMED Corp. has a quarterly dividend of $0.20 per share corresponding to a yield of 1.74%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CONMED Corp. pays 18.82% of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend. CONMED Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CNMD or ELMD?
CONMED Corp. quarterly revenues are $373.5M, which are larger than Electromed, Inc. quarterly revenues of $18.9M. CONMED Corp.'s net income of $16.7M is higher than Electromed, Inc.'s net income of $2.8M. Notably, CONMED Corp.'s price-to-earnings ratio is 30.36x while Electromed, Inc.'s PE ratio is 23.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CONMED Corp. is 1.04x versus 3.06x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CNMDCONMED Corp.1.04x 30.36x $373.5M $16.7M ELMDElectromed, Inc.3.06x 23.43x $18.9M $2.8M
-
Which has Higher Returns CNMD or ESMC?
Escalon Medical Corp. has a net margin of 4.48% compared to CONMED Corp.'s net margin of 2.72%. CONMED Corp.'s return on equity of 4.72% beat Escalon Medical Corp.'s return on equity of -12.94%.
Company Gross Margin Earnings Per Share Invested Capital CNMDCONMED Corp.57.12% $0.54 $1.9B ESMCEscalon Medical Corp.43.33% $0.01 $2.6M -
What do Analysts Say About CNMD or ESMC?
CONMED Corp. has a consensus price target of $47.40, signalling upside risk potential of 3.04%. On the other hand Escalon Medical Corp. has an analysts' consensus of -- which suggests that it could grow by 4900%. Given that Escalon Medical Corp. has higher upside potential than CONMED Corp., analysts believe Escalon Medical Corp. is more attractive than CONMED Corp..
Company Buy Ratings Hold Ratings Sell Ratings CNMDCONMED Corp.0 5 0 ESMCEscalon Medical Corp.0 0 0 -
Is CNMD or ESMC More Risky?
CONMED Corp. has a beta of 0.967, which suggesting that the stock is 3.283% less volatile than S&P 500. In comparison Escalon Medical Corp. has a beta of 0.389, suggesting its less volatile than the S&P 500 by 61.1%.
-
Which is a Better Dividend Stock CNMD or ESMC?
CONMED Corp. has a quarterly dividend of $0.20 per share corresponding to a yield of 1.74%. Escalon Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CONMED Corp. pays 18.82% of its earnings as a dividend. Escalon Medical Corp. pays out -- of its earnings as a dividend. CONMED Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CNMD or ESMC?
CONMED Corp. quarterly revenues are $373.5M, which are larger than Escalon Medical Corp. quarterly revenues of $3.6M. CONMED Corp.'s net income of $16.7M is higher than Escalon Medical Corp.'s net income of $97.7K. Notably, CONMED Corp.'s price-to-earnings ratio is 30.36x while Escalon Medical Corp.'s PE ratio is 154.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CONMED Corp. is 1.04x versus 0.21x for Escalon Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CNMDCONMED Corp.1.04x 30.36x $373.5M $16.7M ESMCEscalon Medical Corp.0.21x 154.45x $3.6M $97.7K
-
Which has Higher Returns CNMD or GTHP?
Guided Therapeutics, Inc. has a net margin of 4.48% compared to CONMED Corp.'s net margin of -1236.67%. CONMED Corp.'s return on equity of 4.72% beat Guided Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CNMDCONMED Corp.57.12% $0.54 $1.9B GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M -
What do Analysts Say About CNMD or GTHP?
CONMED Corp. has a consensus price target of $47.40, signalling upside risk potential of 3.04%. On the other hand Guided Therapeutics, Inc. has an analysts' consensus of -- which suggests that it could grow by 30270170.27%. Given that Guided Therapeutics, Inc. has higher upside potential than CONMED Corp., analysts believe Guided Therapeutics, Inc. is more attractive than CONMED Corp..
Company Buy Ratings Hold Ratings Sell Ratings CNMDCONMED Corp.0 5 0 GTHPGuided Therapeutics, Inc.0 0 0 -
Is CNMD or GTHP More Risky?
CONMED Corp. has a beta of 0.967, which suggesting that the stock is 3.283% less volatile than S&P 500. In comparison Guided Therapeutics, Inc. has a beta of 0.606, suggesting its less volatile than the S&P 500 by 39.441%.
-
Which is a Better Dividend Stock CNMD or GTHP?
CONMED Corp. has a quarterly dividend of $0.20 per share corresponding to a yield of 1.74%. Guided Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CONMED Corp. pays 18.82% of its earnings as a dividend. Guided Therapeutics, Inc. pays out -- of its earnings as a dividend. CONMED Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CNMD or GTHP?
CONMED Corp. quarterly revenues are $373.5M, which are larger than Guided Therapeutics, Inc. quarterly revenues of $60K. CONMED Corp.'s net income of $16.7M is higher than Guided Therapeutics, Inc.'s net income of -$742K. Notably, CONMED Corp.'s price-to-earnings ratio is 30.36x while Guided Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CONMED Corp. is 1.04x versus 150.88x for Guided Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CNMDCONMED Corp.1.04x 30.36x $373.5M $16.7M GTHPGuided Therapeutics, Inc.150.88x -- $60K -$742K
-
Which has Higher Returns CNMD or IRIX?
IRIDEX Corp. has a net margin of 4.48% compared to CONMED Corp.'s net margin of -12.6%. CONMED Corp.'s return on equity of 4.72% beat IRIDEX Corp.'s return on equity of -155.93%.
Company Gross Margin Earnings Per Share Invested Capital CNMDCONMED Corp.57.12% $0.54 $1.9B IRIXIRIDEX Corp.32.15% -$0.09 $9.5M -
What do Analysts Say About CNMD or IRIX?
CONMED Corp. has a consensus price target of $47.40, signalling upside risk potential of 3.04%. On the other hand IRIDEX Corp. has an analysts' consensus of $3.00 which suggests that it could grow by 105.48%. Given that IRIDEX Corp. has higher upside potential than CONMED Corp., analysts believe IRIDEX Corp. is more attractive than CONMED Corp..
Company Buy Ratings Hold Ratings Sell Ratings CNMDCONMED Corp.0 5 0 IRIXIRIDEX Corp.1 0 0 -
Is CNMD or IRIX More Risky?
CONMED Corp. has a beta of 0.967, which suggesting that the stock is 3.283% less volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.705, suggesting its less volatile than the S&P 500 by 29.514%.
-
Which is a Better Dividend Stock CNMD or IRIX?
CONMED Corp. has a quarterly dividend of $0.20 per share corresponding to a yield of 1.74%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CONMED Corp. pays 18.82% of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend. CONMED Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CNMD or IRIX?
CONMED Corp. quarterly revenues are $373.5M, which are larger than IRIDEX Corp. quarterly revenues of $12.5M. CONMED Corp.'s net income of $16.7M is higher than IRIDEX Corp.'s net income of -$1.6M. Notably, CONMED Corp.'s price-to-earnings ratio is 30.36x while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CONMED Corp. is 1.04x versus 0.48x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CNMDCONMED Corp.1.04x 30.36x $373.5M $16.7M IRIXIRIDEX Corp.0.48x -- $12.5M -$1.6M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 13.92% over the past day.
Buy
83
GCT alert for Feb 28
GigaCloud Technology, Inc. [GCT] is down 5.87% over the past day.
Buy
62
LMAT alert for Feb 27
LeMaitre Vascular, Inc. [LMAT] is down 4.76% over the past day.
